SYLVATICA BIOTECH INC
North Charleston, SC · Medtech · Private
Liver preservation and perfusion system extending donor organ viability from 6-10 hours to 5-7 days through optimized stasis cocktails and advanced perfusion devices
sylvaticabio.com →- Grants
- $23M
- 39 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $1.8M
- 4 awards · Defense
- #235 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · Dhp Phase I Proposal H151-013-0141 Igf::ot::igf | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase I · High Subzero, Equilibrium VCA Cryopreservation | $224,998 | |
| Federal grant | Department of Health and Human Services · Phase I · Sylvatica I Corps Commercialization Jan High Subzero Equilibrium VCA Cryopreservation | $274,998 | |
| Federal grant | Department of Health and Human Services · Phase I · Isochoric Pressure Based Preservation of Cells, Tissues and Organs | $223,529 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Sylvatica I-Corps Commercialization March2017- Isochoric Pressure Based Preservation of Ovarian Tissue | $275,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Isochoric Pressure Based Preservation of Ovarian Tissue | $225,000 | |
| Federal grant | Department of Defense · Phase I · Salvage of whole reproductive organs through next-generation perfusion, cryoprotection, and nanowarming | $150,000 | |
| Federal contract | Department of Defense · Igf::ot::igf SBIR Phase II Dhp 15.1 H2-0185 | $1,010,000 | |
| Federal contract | Department of Defense · Igf::ot::igf Army Phase I Proposal A161-050-0981 | $100,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Sylvatica I-Corps Commercialization Jan2017 - High Subzero, Equilibrium VCA Cryopreservation | $50,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Nature-inspired methods for long-term banking of endocrine cells within encapsulation devices | $224,347 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Isochoric Pressure Assisted Vitrification of Testicular Tissue and Whole Testes | $285,084 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Isochoric Pressure Assisted Vitrification of Testicular Tissue and Whole Testes | $285,084 | |
| Federal grant | Department of Health and Human Services · Phase I · Sylvatica I-Corps Commercialization March2017- Isochoric Pressure Based Preservation of Ovarian Tissue | $50,000 | |
| Federal grant | Department of Health and Human Services · Phase II · High Subzero Equilibrium VCA Cryopreservation | $622,651 | |
| Federal grant | Department of Health and Human Services · Phase II · High Subzero Equilibrium VCA Cryopreservation | $1,934,415 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Nanowarming-enabled vitrification for banking human livers | $284,002 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Nanowarming-enabled vitrification for banking human livers | $284,002 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Nanowarming and banking of kidneys and kidney slices following metabolic preconditioning and multi-temperature machine perfusion | $219,084 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Nanowarming and banking of kidneys and kidney slices following metabolic preconditioning and multi-temperature machine perfusion | $219,084 | |
| Federal grant | Department of Health and Human Services · Phase II · Isochoric Pressure Based Preservation of Cells, Tissues and Organs | $428,799 | |
| Federal grant | Department of Health and Human Services · Phase II · High Subzero Equilibrium VCA Cryopreservation | $897,200 | |
| Federal grant | Department of Health and Human Services · Phase I · New approaches to kidney banking through nature-inspired high sub-zeropreservation strategies | $248,680 | |
| Federal grant | Department of Health and Human Services · Phase II · Fertility Protection in Cancer: Recovery of Whole Ovaries enabled by Next Gen Perfusion, Cryoprotection, and Nanowarming | $655,915 | |
| Federal grant | Department of Health and Human Services · Phase II · Fertility Protection in Cancer: Recovery of Whole Ovaries enabled by Next Gen Perfusion, Cryoprotection, and Nanowarming | $1,601,008 | |
| Federal grant | Department of Health and Human Services · Phase II · Extended preservation of human livers: a nature inspired, high subzero controlled, limited freezing approach | $299,706 | |
| Federal grant | Department of Health and Human Services · Phase I · Non-toxic, nature-inspired perfusion and high subzero ice-free isochoric technologies for extending heart preservation | $231,940 | |
| Federal grant | Department of Health and Human Services · Phase I · Non-toxic, nature-inspired perfusion and high subzero ice-free isochoric technologies for extending heart preservation | $231,940 | |
| Federal grant | Department of Health and Human Services · Phase II · Isochoric Pressure Based Preservation of Cells, Tissues and Organs | $874,140 | |
| Federal grant | Department of Health and Human Services · Phase II · High Subzero Equilibrium VCA Cryopreservation | $414,564 | |
| Federal grant | Department of Health and Human Services · Phase II · Fertility Protection in Cancer: Recovery of Whole Ovaries enabled by Next Gen Perfusion, Cryoprotection, and Nanowarming | $584,070 | |
| Federal grant | Department of Health and Human Services · Phase II · Isochoric Pressure Based Preservation of Cells, Tissues and Organs | $890,768 | |
| Federal contract | Department of Defense · Award Of Sylvatica's Dha SBIR Phase II Enhancement Medical R&d Contract For "development Of A Novel Cryostasis Cocktail And Protocol For High Subzero Banking Of Human Organs" | $549,604 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Isochoric Pressure Based Preservation of Ovarian Tissue | $1,958,572 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Isochoric Pressure Based Preservation of Ovarian Tissue | $587,829 | |
| Federal grant | Department of Health and Human Services · Phase II · Isochoric Pressure Based Preservation of Ovarian Tissue | $829,142 | |
| Federal grant | Department of Health and Human Services · Phase II · Extended preservation of human livers: a nature inspired, high subzero controlled, limited freezing approach | $705,323 | |
| Federal grant | Department of Health and Human Services · Phase II · Extended preservation of human livers: a nature inspired, high subzero controlled, limited freezing approach | $1,631,788 | |
| Federal grant | Department of Health and Human Services · Phase II · Extended preservation of human livers: a nature inspired, high subzero controlled, limited freezing approach | $926,465 | |
| Federal grant | Department of Health and Human Services · Phase II · Isochoric Pressure Based Preservation of Ovarian Tissue | $541,601 | |
| Federal grant | Department of Health and Human Services · Phase II · Extended preservation of human livers: a nature inspired, high subzero controlled, limited freezing approach | $361,067 | |
| Federal grant | Department of Health and Human Services · Phase II · Enhanced supercooling for extending non-freezing preservation in preclinical porcine and human donor livers | $965,379 | |
| Federal grant | Department of Health and Human Services · Phase II · Enhanced supercooling for extending non-freezing preservation in preclinical porcine and human donor livers | $980,782 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 232 | ARETECH, LLC | $1.9M | — |
| 233 | Natera | $1.9M | — |
| 234 | ACCELERATED MEDICAL DIAGNOSTICS, INC | $1.9M | — |
| 235 | SYLVATICA BIOTECH INC | $1.8M | — |
| 236 | Redbud Labs, Inc. | $1.8M | $520K |
| 237 | Particle Metrix | $1.8M | — |
| 238 | ROSELLINI SCIENTIFIC, LLC | $1.8M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.